Tag: fine

New Scientific Discovery in Resistant Starch Awakens Metabolic Signals That Vanish After 35 — Helping Over 147,000 Women Reclaim Fat Loss Without Diets, Injections, or Tracking

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- In a moment when consumers are demanding clarity and credibility across every purchase—from clean beauty to conflict-free diamonds—She Said Yes, the sustainable fine jewelry brand, is leading with proof announcing rigorous testing, international certification, and thousands of verified five-star reviews.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- With consumers increasingly searching for comfortable rings, hypoallergenic fine jewelry, and daily-wear engagement rings, She Said Yes is answering the call—introducing a new design standard that blends beauty with all-day comfort.

CELEBRATION, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare diseases, announced the company submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for the evaluation of arimoclomol for the treatment of Niemann-Pick Disease Type C (NPC). NPC is an ultra-rare, neurological disease caused by genetic mutations that result in lipid accumulation in cells, leading to visceral, neurological, and psychiatric symptoms. Arimoclomol is the only treatment shown to directly target the underlying pathology of NPC by increasing gene expression for improved lipid clearance. Arimoclomol for the treatment of NPC has been designated as an Orphan Medicinal Product by the EMA. Arimoclomol is marketed in the U.S. under the brand name MIPLYFFA®.